Heart failure is a serious, chronic condition. While medication can help the heart recover and improve its function, this study suggests that the medications themselves may continue to protect the ...

BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study ...

While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as high as 17% of the population.

In it, the researchers explain that they used single-cell and spatial data to learn how myeloid cells affect the immune system’s response ... was stronger as the drug dose increased.

Recently, the National Agency for Food and Drug Administration and Control (NAFDAC) in Alliance with the Pharmacy Council of Nigeria (PCN) has closed down several major open drug markets in Nigeria ...

In such cases the physician must decide whether to increase the medication that the patient is already taking, add a second or third drug ... with a reactive renin system should have an increased ...

in combination with the classical renin-angiotensin-aldosterone system (RAAS) blockers are promising therapies (7). Patients with LN are excluded from studies with new nephroprotective agents, leading ...

trial drug discontinuation due to renal events, systematic hypotension, hyperkalemia, and severe hyperkalemia. Outcomes were from fixed-effect meta-analysis. RAASi, renin–angiotensin–aldosterone ...

7 Figure. Schematic illustrating mechanotransduction pressure-sensing system in renin-expressing cells: integrin β1 and Cx40 (connexin 40) are players in the pressure-sensing machinery. Crosstalk ...